Using advocates to boost lung cancer screening rates
Utilizing Spheres of Influence to Increase Cancer Screening: Empowering Community Health Advocates
This study is testing if having advocates and support can help more people get screened for lung cancer by addressing their concerns and encouraging them to share information with others.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 800 (estimated) |
| Ages | 40 Years to 80 Years |
| Sex | All |
| Sponsor | Jonsson Comprehensive Cancer Center Academic / other |
| Locations | 1 site (Los Angeles, California) |
| Trial ID | NCT05978128 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of advocates and supporters in increasing lung cancer screening rates among eligible participants. It focuses on understanding the psychological barriers that prevent individuals from participating in lung screening, compared to the more widely accepted breast cancer screening. Participants will access educational materials and interact with a patient navigator, while also being encouraged to share information about the benefits of screening with their social circles. The study aims to identify the number of patients eligible for lung screening and assess the role of current cancer screening participants as advocates.
Who should consider this trial
Good fit: Ideal candidates include individuals aged 50-80 who are current, former, or never smokers and have a close family or friend with a smoking history.
Not a fit: Patients who are under 50 or over 80 years old, or those with a prior diagnosis of lung cancer or active cancer, may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly increase lung cancer screening rates, leading to earlier detection and potentially improved survival outcomes for patients.
How similar studies have performed: Other studies have shown success in using advocacy and education to improve cancer screening rates, suggesting that this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age: * Breast screening \> 40 * Lung screening 50-80 * Male (M) or Female (F) * Current, former, or never smokers * Close family or friend with smoking history (in or out of state) Exclusion Criteria: * Age: * Breast screening \< 40 * Lung screening \< 50 or \> 80 * Persons who had previously received a diagnosis of lung cancer, had hemoptysis, or had an unexplained weight loss of more than 6.8 kg (15 lb) in the preceding year will also be excluded * Persons with an active cancer
Where this trial is running
Los Angeles, California
- UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California, United States (Recruiting)
Study contacts
- Principal investigator: Ashley E Prosper — UCLA / Jonsson Comprehensive Cancer Center
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.